-
Categories
-
Pharmaceutical Intermediates
-
Active Pharmaceutical Ingredients
-
Food Additives
- Industrial Coatings
- Agrochemicals
- Dyes and Pigments
- Surfactant
- Flavors and Fragrances
- Chemical Reagents
- Catalyst and Auxiliary
- Natural Products
- Inorganic Chemistry
-
Organic Chemistry
-
Biochemical Engineering
- Analytical Chemistry
- Cosmetic Ingredient
-
Pharmaceutical Intermediates
Promotion
ECHEMI Mall
Wholesale
Weekly Price
Exhibition
News
-
Trade Service
Non-alcoholic steatohepatitis (NASH) is a subtype of non-alcoholic fatty liver disease (NAFLD) and has become an increasingly common liver disease.
NASH may cause chronic liver disease, cirrhosis and hepatocellular carcinoma
.
In view of its increasing incidence and prevalence, NASH has become the main cause of liver transplantation
Non-alcoholic steatohepatitis (NASH) is a subtype of non-alcoholic fatty liver disease (NAFLD) and has become an increasingly common liver disease.
Researchers conducted a retrospective cohort study using a 2016 sample data set of hospitalized patients across the United States, which included adult patients hospitalized with NASH, and stratified risk based on the presence of renal failure
.
The main observation is hospital mortality, and multivariate logistic regression is used to analyze predictive factors
The results of the study showed that a total of 7135090 patients were enrolled
.
Of the 6855 patients admitted to the hospital for NASH, 598 (8.
Figure: Risk factors affecting the prognosis of NASH patients
This study finally confirmed that the prevalence of renal failure during NASH hospitalization is related to a significant increase in mortality, hospitalization costs, and length of stay
.
Therefore, clinicians should remain vigilant when treating NASH patients with renal failure
This study finally confirmed that the prevalence of renal failure during NASH hospitalization is related to a significant increase in mortality, hospitalization costs, and length of stay
Original source:
Reja, Mishal.
Renal Failure is Associated With Increased Mortality and Hospital Utilization in Patients Admitted With Nonalcoholic Steatohepatitis.
Leave a message here